CN104585746A - 一种供糖尿病人食用的特殊膳食食品生产方法 - Google Patents
一种供糖尿病人食用的特殊膳食食品生产方法 Download PDFInfo
- Publication number
- CN104585746A CN104585746A CN201410802999.1A CN201410802999A CN104585746A CN 104585746 A CN104585746 A CN 104585746A CN 201410802999 A CN201410802999 A CN 201410802999A CN 104585746 A CN104585746 A CN 104585746A
- Authority
- CN
- China
- Prior art keywords
- food
- powder
- gram
- grams
- special
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 26
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 23
- 235000005911 diet Nutrition 0.000 title claims abstract description 15
- 230000000378 dietary effect Effects 0.000 title abstract description 5
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 32
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 235000000832 Ayote Nutrition 0.000 claims abstract description 11
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 11
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 11
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 11
- 230000037213 diet Effects 0.000 claims abstract description 10
- 240000004507 Abelmoschus esculentus Species 0.000 claims abstract description 9
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 8
- 239000003765 sweetening agent Substances 0.000 claims abstract description 8
- 239000000811 xylitol Substances 0.000 claims abstract description 8
- 235000010447 xylitol Nutrition 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 8
- 229960002675 xylitol Drugs 0.000 claims abstract description 8
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000411851 herbal medicine Species 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 4
- 238000011049 filling Methods 0.000 claims abstract description 3
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 32
- 244000077995 Coix lacryma jobi Species 0.000 claims description 9
- 240000004244 Cucurbita moschata Species 0.000 claims description 9
- 235000003934 Abelmoschus esculentus Nutrition 0.000 claims description 8
- 244000302512 Momordica charantia Species 0.000 claims description 8
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims description 8
- 235000004347 Perilla Nutrition 0.000 claims description 8
- 244000124853 Perilla frutescens Species 0.000 claims description 8
- 244000046146 Pueraria lobata Species 0.000 claims description 8
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 8
- 244000241872 Lycium chinense Species 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000000428 dust Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 17
- 238000005507 spraying Methods 0.000 abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 5
- 239000008103 glucose Substances 0.000 abstract description 5
- 235000013325 dietary fiber Nutrition 0.000 abstract description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 abstract description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 abstract description 3
- 240000001980 Cucurbita pepo Species 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 238000005457 optimization Methods 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000003914 insulin secretion Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000000889 atomisation Methods 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- -1 carrotene Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229930185803 charantin Natural products 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002727 hyperosmolar Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000001937 intercostal nerve Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种供糖尿病人食用的特殊膳食蛋白粉的生产方法,属于特殊膳食食品领域。该食品以脱脂奶粉、大豆分离蛋白粉和南瓜粉为主要原料,添加燕麦粉、苦瓜粉、秋葵等食品原料,辅以葛根、枸杞子、紫苏籽、薏苡仁、黑芝麻等药食两用中草药,添加甜味剂木糖醇,组成特殊膳食用食品配方。通过原料处理、混合、磨浆、均质、喷粉、灌装等步骤,制成粉末状食品,温开水溶解后食用。一本方法制备的特殊膳食用食品,溶解性强,含糖量低,富含膳食纤维和多种维生素,对糖尿病人饮食结构优化,改善血糖水平具有显著作用。
Description
技术领域
本发明涉及一种供糖尿病人食用的特殊膳食用蛋白粉生产方法,属于特殊膳食用食品领域。
背景技术
糖尿病是一组由于胰岛素分泌缺陷或胰岛素作用障碍所致的以高血糖为特征的代谢性疾病。持续高血糖与长期代谢紊乱可导致全身组织器官,特别是眼睛、肾脏、心血管及神经***的损害及其功能障碍甚至衰竭,严重者可引起失水,电解质紊乱和酸碱平衡失调等急性并发症酮症酸中毒和高渗性昏迷。
糖尿病的临床表现中的典型症状为三多一少,即多食、多饮、多尿和体重减少。急性并发症表现为应激等情况下病情加重,可出现食欲减退、恶心、呕吐、腹痛,多尿加重等症状。慢性并发症主要包含:糖尿病视网膜病变,糖尿病性肾病,糖尿病神经病变,反复感染等。
据不完全统计,糖尿病在我国的发病率达到2%,现已确诊的糖尿病患者已超过4000万,并以每年100万的速度递增,而在医学界还没有能完全治愈这种病症的特效药。
目前针对糖尿病的治疗方式主要有药物治疗和一般疗法两大类。
在药物治疗方面,可分为口服降糖药、注射胰岛素等形式。口服降糖药物的选择要根据糖尿病的主要病理生理改变的实质,同时结合患者的血糖波动特点、年龄、体重、重要器官脏器功能等因素,联合用药时要采用具有互补机制的药物,以增加疗效,降低不良反应的发生率。但是口服降糖药物都存在不同副作用,在降低血糖的同时对身体造成一定的损伤。注射胰岛素,效果显著,但是存在依赖性强,同时容易造成低血糖反应。因此,患者在用药方面,一定要结合自身具体情况,与医生沟通,制定合理的治疗方案。
一般治疗首先要注意劳逸结合,保持充足的睡眠,进行适当的体育锻炼;同时要注意饮食结构的调整,以清淡素食、粗粮、杂面为主,多吃低糖食物,减少碳水化合物含量高的食物,合理均衡分配各种营养物质。
针对当前糖尿病的一般治疗现状,开发一种以脱脂奶粉、大豆分离蛋白和南瓜粉为主要原料的供糖尿病人食用的特殊膳食用食品,缓解血糖升高,调节胰岛素分泌水平,降低各种糖尿病并发症的危害具有重要作用。
发明内容
本发明目的是开发一种供糖尿病人食用的特殊膳食用食品,以解决糖尿病人专用食品少的难题。
为了解决上述技术问题,本发明采用以下技术方案予以实现:以脱脂奶粉、大豆分离蛋白粉和南瓜粉为主要原料,添加燕麦粉、苦瓜粉、秋葵等食品原料,辅以葛根、枸杞子、紫苏籽、薏苡仁、黑芝麻等药食两用中草药,添加甜味剂木糖醇,组成特殊膳食用食品配方,每100克中,含有脱脂奶粉30-50克,大豆分离蛋白粉34-54克,南瓜粉5-10克,燕麦粉5-10克,苦瓜粉3-5克,秋葵2-5克,药食两用中草药共计10克,葛根2-4克,枸杞子1.5-3克,紫苏籽2.2-3克,薏苡仁1.8-3.2克,黑芝麻1-3克,甜味剂木糖醇2克。
南瓜:又称倭瓜,其味甘,性温,有补中益气、润肺化痰作用,亦可治气虚乏力、肋间神经通等症,南瓜含有丰富的果胶和微量元素钴,果胶可延缓肠道对糖和脂质的吸收,钴是胰岛细胞合成胰岛素所必需的微量元素。
燕麦:含有粗蛋白达15.6%,脂肪8.5%,燕麦中水溶性膳食纤维是小麦的4.7倍、玉米的7.7倍,丰富的膳食纤维可导致食物在胃里的停留时间,推迟小肠对淀粉的消化吸收,水溶性的膳食纤维可在肠内形成黏状物,将食物包裹,减缓餐后血糖上升,起到控制和调节血糖的作用。同时,燕麦中所含的不饱和脂肪酸及可溶性皂苷素等可以降低血液中胆固醇与甘油三酯的含量,帮助降低血糖。
苦瓜:味苦、无毒、性寒,入心、肝、脾、肺经,具有清热祛暑、清热解毒、清心明目、益气解乏、益肾利尿的作用。苦瓜中含有的苦瓜甙可促进肌肉细胞和脂肪组织对血糖的吸收和利用,并可增强肝脏和肌肉中糖原的合成,抑制糖再生,从而降低血糖。另外可活化及修复胰腺细胞,促进胰岛素分泌,提高血糖利用率。
秋葵:味淡、性寒,具有利咽、通淋等功效,可用于预防糖尿病,保护胃粘膜。秋葵含有果胶、牛乳聚糖等成分,具有帮助消化、治疗胃炎和胃溃疡之功效,富含的锌和硒等微量元素能增强人体防癌抗癌的作用,丰富的可溶性纤维可阻止肠道碳水化合物的消化进而降低葡萄糖的吸收,从而达到降低血糖的功效。
葛根:味甘性凉,归脾、胃、肺经,具有解肌退热、生津止渴、升阳止泻之功效。葛根中含有的葛根素具有修复和保护胰岛细胞,抑制胰高血糖素分泌而促进胰岛素分泌的作用,从而达到降低血糖的效果。另外,葛根素可以明显改善糖尿病视网膜病变症状,保护和强化肾功能,有效控制糖尿病及其并发症。
枸杞子:含有胡萝卜素、维生素 B1、维生素 B2、烟酸、维生素 C、维生素 E、多 种游离氨基酸、亚油酸、甜芋碱、铁、钾、锌、钙、磷等成分,味甘,性平,入肝、肾、肺经,有滋补肝肾、益精明目、和血润燥、解热消渴等功效。
紫苏籽:味辛,性温,归肺、胃、大肠经,质润和降,具有降气消痰,止咳平喘,宽肠润便等功效。紫苏籽含糖量低,富含α-亚麻酸,具有降血脂,抑制肿瘤,抑制血小板凝集,防止血栓形成等功能。
薏苡仁:性凉,味甘、淡,具有健脾渗湿,除痹止泻,利水肿肿、清热排脓等功效。薏苡仁油对细胞免疫、体液免疫有促进作用,可以增强人体免疫力;薏苡仁中富含的B族维生素可防治糖尿病并发症,所含有的扩张血管的物质有益于高血压等糖尿病血管并发症的防治。
黑芝麻:味甘、平,归肝、肾、大肠经,具有补肝肾、益精血、润肠燥等作用。富含维生素A、维生素E、卵磷脂、钙、铁、铬及不饱和脂肪酸等营养成分,能增加肝脏及肌肉中糖原的含量,降低血糖水平的作用。
木糖醇:为糖醇的一种,甜度与蔗糖相当,但热量只有蔗糖的60%,在体内代谢不需要胰岛素参与,又不使血糖值升高,是糖尿病人安全的甜味剂、营养补充剂和辅助治疗剂。
本发明是通过特殊膳食食品加工方法制备而成的。
1、称重:准确称取各类原料。
2、混合:将上述具体原料混合,搅拌均匀。
3、浸泡:将上步骤2中混合好的混合物放入清水中100℃浸泡3-4小时。
4、磨浆:将上步骤3中浸泡好的混合物放入磨浆机中磨成糊状。
5、均质:将上步骤4中磨浆好的混合物通过均质机将其通过挤压、强冲击和失压膨胀三重作用,使混合物更细化,从而使得混合物混合更加均匀,其中压力设置为20-25MPa,温度设置为60-75℃。
6、喷雾干燥:将上述步骤5中的混合物通过喷雾干燥器将混合物中的水分快速蒸发,进风温度控制在130-140℃,出风温度控制在80-90℃,雾化度为76%-88%。
7、罐装:将上述步骤6中喷雾干燥得到的混合物粉末罐装,每罐500克。
与现有技术相比,本发明的优点是安全性高,没有副作用,食用方便,在补充糖尿病人基本营养的同时合理改善饮食结构,调节血糖水平,修复胰岛细胞,对糖尿病人具有特殊治疗作用。
具体实施方式
下面结合具体实施例对本发明做进一步说明,但是这些实例并不限制本发明的范围。此外,相关领域的普通技术人员对本发明做的任何改动,只要不脱离本发明的实质,都将等价落在本发明权利要求书所限定的范围内。
实施例1
(1) 称量:准确称取脱脂奶粉350克,大豆分离蛋白粉340克,南瓜粉60克,燕麦粉60克,苦瓜粉35克,秋葵35克,葛根20克,枸杞子20克,紫苏籽20克,薏苡仁20克,黑芝麻20克,甜味剂木糖醇20克,所有原料共1000克。(2)混合:将所有原料混合,搅拌均匀。(3)浸泡:将混合好的混合物放入100℃清水中浸泡3.5小时。(4)磨浆:将上述步骤浸泡好的混合物放入磨浆机中制成糊状。(5)均质:将磨浆后混合物通过均质机将混合物通过挤压、强冲击和失压膨胀的三重作用下使混合物更加的细化,从而使混合物更加均匀,其中,将压力设置为23MPa,温度设置为65℃。(6)喷雾干燥:将上述步骤中的混合物通过喷雾器将混合物中的水分快速蒸发,其中,进风温度设置为130℃,出风温度控制在86℃,雾化度为78%。(7)罐装:将喷雾干燥得到的粉末罐装,每罐500克。
糖尿病人每天取50-60克食用,一个月后,血糖趋于平稳,血糖指数明显改善,35%的人身体机能显著改善。
实施例2
(1) 称量:准确称取脱脂奶粉3200克,大豆分离蛋白粉3450克,南瓜粉600克,燕麦粉700克,苦瓜粉450克,秋葵400克,葛根300克,枸杞子150克,紫苏籽200克,薏苡仁200克,黑芝麻150克,甜味剂木糖醇200克,所有原料共10000克。(2)混合:将所有原料混合,搅拌均匀。(3)浸泡:将混合好的混合物放入100℃清水中浸泡4小时。(4)磨浆:将上述步骤浸泡好的混合物放入磨浆机中制成糊状。(5)均质:将磨浆后混合物通过均质机将混合物通过挤压、强冲击和失压膨胀的三重作用下使混合物更加的细化,从而使混合物更加均匀,其中,将压力设置为25MPa,温度设置为70℃。(6)喷雾干燥:将上述步骤中的混合物通过喷雾器将混合物中的水分快速蒸发,其中,进风温度设置为135℃,出风温度控制在87℃,雾化度为80%。(7)袋装:将喷雾干燥得到的粉末罐装,每袋60克。
糖尿病人每天取一袋食用,两个月后,身体机能明显改善,血糖指数较为平稳, 55%的人症状显著改善。
Claims (2)
1.一种供糖尿病人食用的特殊膳食蛋白粉生产方法其特征在于,它是以脱脂奶粉、大豆分离蛋白粉和南瓜粉为主要原料,添加燕麦粉、苦瓜粉、秋葵等食品原料,辅以葛根、枸杞子、紫苏籽、薏苡仁、黑芝麻等药食两用中草药,添加甜味剂木糖醇,组成特殊膳食用食品配方,通过原料处理、混合、磨浆、均质、喷粉、灌装等步骤,制成粉末状食品,温开水溶解后食用。
2.根据权利要求1所述的特殊膳食用食品配方,每100克中,含有脱脂奶粉30-50克,大豆分离蛋白粉34-54克,南瓜粉5-10克,燕麦粉5-10克,苦瓜粉3-5克,秋葵2-5克,药食两用中草药共计10克,葛根2-4克,枸杞子1.5-3克,紫苏籽2.2-3克,薏苡仁1.8-3.2克,黑芝麻1-3克,甜味剂木糖醇2克。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410802999.1A CN104585746A (zh) | 2014-12-23 | 2014-12-23 | 一种供糖尿病人食用的特殊膳食食品生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410802999.1A CN104585746A (zh) | 2014-12-23 | 2014-12-23 | 一种供糖尿病人食用的特殊膳食食品生产方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104585746A true CN104585746A (zh) | 2015-05-06 |
Family
ID=53112081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410802999.1A Pending CN104585746A (zh) | 2014-12-23 | 2014-12-23 | 一种供糖尿病人食用的特殊膳食食品生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104585746A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105124576A (zh) * | 2015-08-21 | 2015-12-09 | 刘涛 | 一种辅助降血糖的保健食品制备方法 |
CN105146289A (zh) * | 2015-08-21 | 2015-12-16 | 刘涛 | 一种辅助降血脂的保健品制备方法 |
CN105380073A (zh) * | 2015-10-21 | 2016-03-09 | 王评 | 一种糖尿病营养餐冲剂 |
CN107006761A (zh) * | 2017-03-20 | 2017-08-04 | 西藏晶稞食品有限公司 | 一种适于糖尿病患者食用的营养代餐粉及其制备方法 |
CN108783441A (zh) * | 2018-04-13 | 2018-11-13 | 湖州天维生物科技有限公司 | 一种降血糖的功能性食品及其制作方法 |
CN109965290A (zh) * | 2017-12-27 | 2019-07-05 | 深圳华大生命科学研究院 | 改善肠道菌群代餐粉及其应用 |
CN112385767A (zh) * | 2020-10-14 | 2021-02-23 | 北京金三七科技有限公司 | 一种将三七花用于调理便秘、双向调节血糖的食品及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1212134A (zh) * | 1997-09-24 | 1999-03-31 | 肖克佑 | 一种对糖尿病有防治作用的食品 |
CN1623411A (zh) * | 2004-12-16 | 2005-06-08 | 广东省农业科学院农业生物技术研究所 | 一种复合蛋白粉及其制备方法 |
CN101986878A (zh) * | 2009-08-06 | 2011-03-23 | 孙德娟 | 一种养生保健营养豆奶粉及其制作方法 |
CN102813195A (zh) * | 2012-08-06 | 2012-12-12 | 广水市东晨农业科技有限公司 | 一种含有黄秋葵的降血糖食品及其制备方法 |
CN103110103A (zh) * | 2013-03-13 | 2013-05-22 | 广州朗姿贸易有限公司 | 清脂减肥营养餐粉 |
CN103125949A (zh) * | 2013-02-23 | 2013-06-05 | 谷神生物科技集团有限公司 | 一种高纤维蛋白粉 |
CN103445185A (zh) * | 2013-09-02 | 2013-12-18 | 青岛贝尔特生物科技有限公司 | 一种女性专用海洋蛋白粉及制备方法 |
CN103504305A (zh) * | 2013-10-28 | 2014-01-15 | 王伏春 | 一种具有降血糖功能的保健品及其制备方法 |
-
2014
- 2014-12-23 CN CN201410802999.1A patent/CN104585746A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1212134A (zh) * | 1997-09-24 | 1999-03-31 | 肖克佑 | 一种对糖尿病有防治作用的食品 |
CN1623411A (zh) * | 2004-12-16 | 2005-06-08 | 广东省农业科学院农业生物技术研究所 | 一种复合蛋白粉及其制备方法 |
CN101986878A (zh) * | 2009-08-06 | 2011-03-23 | 孙德娟 | 一种养生保健营养豆奶粉及其制作方法 |
CN102813195A (zh) * | 2012-08-06 | 2012-12-12 | 广水市东晨农业科技有限公司 | 一种含有黄秋葵的降血糖食品及其制备方法 |
CN103125949A (zh) * | 2013-02-23 | 2013-06-05 | 谷神生物科技集团有限公司 | 一种高纤维蛋白粉 |
CN103110103A (zh) * | 2013-03-13 | 2013-05-22 | 广州朗姿贸易有限公司 | 清脂减肥营养餐粉 |
CN103445185A (zh) * | 2013-09-02 | 2013-12-18 | 青岛贝尔特生物科技有限公司 | 一种女性专用海洋蛋白粉及制备方法 |
CN103504305A (zh) * | 2013-10-28 | 2014-01-15 | 王伏春 | 一种具有降血糖功能的保健品及其制备方法 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105124576A (zh) * | 2015-08-21 | 2015-12-09 | 刘涛 | 一种辅助降血糖的保健食品制备方法 |
CN105146289A (zh) * | 2015-08-21 | 2015-12-16 | 刘涛 | 一种辅助降血脂的保健品制备方法 |
CN105380073A (zh) * | 2015-10-21 | 2016-03-09 | 王评 | 一种糖尿病营养餐冲剂 |
CN107006761A (zh) * | 2017-03-20 | 2017-08-04 | 西藏晶稞食品有限公司 | 一种适于糖尿病患者食用的营养代餐粉及其制备方法 |
CN109965290A (zh) * | 2017-12-27 | 2019-07-05 | 深圳华大生命科学研究院 | 改善肠道菌群代餐粉及其应用 |
CN109965290B (zh) * | 2017-12-27 | 2023-06-20 | 深圳华大生命科学研究院 | 改善肠道菌群代餐粉及其应用 |
CN108783441A (zh) * | 2018-04-13 | 2018-11-13 | 湖州天维生物科技有限公司 | 一种降血糖的功能性食品及其制作方法 |
CN112385767A (zh) * | 2020-10-14 | 2021-02-23 | 北京金三七科技有限公司 | 一种将三七花用于调理便秘、双向调节血糖的食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210352948A1 (en) | Composition for treating diabetes based on traditional Chinese medicine nutritional therapy and application thereof | |
CN104585746A (zh) | 一种供糖尿病人食用的特殊膳食食品生产方法 | |
CN103229963B (zh) | 一种经发芽处理的杂粮食品及其制备方法 | |
CN110326780A (zh) | 一种具有降血糖功能的营养代餐及其制备方法 | |
CN103504305B (zh) | 一种具有降血糖功能的保健品及其制备方法 | |
CN104431741B (zh) | 一种谷物调理粥及其制备方法和用途 | |
CN106983052A (zh) | 一种辅助降血糖的固体饮料及其制备方法 | |
CN102648752B (zh) | 一种适于膳食失衡人群有降血糖功能的工程米及制备方法 | |
CN102524659A (zh) | 一种具有营养保健功能的粮食配方 | |
CN106666312A (zh) | 一种辅助降血糖的保健食品及其颗粒剂和胶囊剂制备方法 | |
CN103211162A (zh) | 一种经发酵处理的杂粮食品及其制备方法 | |
CN103493865A (zh) | 一种适合高血压人群食用的饼干及其制备方法 | |
CN108391785A (zh) | 一种功能性代餐粉及其制作工艺与应用 | |
CN104642962A (zh) | 一种淮山营养保健粉及其制作方法 | |
CN107212416A (zh) | 一种糖尿病全营养配方食品的制备方法及应用 | |
CN104172168A (zh) | 一种调理动脉粥样硬化的方便食品 | |
CN105707681A (zh) | 一种具有降血糖功能的超微黑木耳粉营养粥及其制备方法 | |
CN103734217A (zh) | 一种铁皮石斛降糖助消化面粉 | |
CN102871129A (zh) | 一种淮山复合营养米 | |
CN104720069A (zh) | 一种山药大枣维生素强化固体饮料及其制备方法 | |
CN103932003A (zh) | 一种开胃粉丝 | |
CN102150779B (zh) | 一种调节及稳定血糖的保健食品及制备方法 | |
KR102278071B1 (ko) | 곡물 건강식품 및 이의 제조방법 | |
CN105010628B (zh) | 一种女性减肥保健袋泡茶 | |
CN105495584A (zh) | 一种增强机体免疫力的以花生蛋白为主的食品生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150506 |
|
RJ01 | Rejection of invention patent application after publication |